TrialNature cancer2026

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.

Rebecca A Burrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.